Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.

Details

Serval ID
serval:BIB_41768A5E0562
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
Journal
Digestive endoscopy
Author(s)
Marx M., Godat S., Caillol F., Poizat F., Ratone J.P., Pesenti C., Schoepfer A., Hoibian S., Dahel Y., Giovannini M.
ISSN
1443-1661 (Electronic)
ISSN-L
0915-5635
Publication state
In Press
Peer-reviewed
Oui
Language
english
Notes
Publication types: Journal Article
Publication Status: aheadofprint
Abstract
Recently, there has been growing interest in investigating endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for the management of small non-functional pancreatic neuroendocrine tumors (nf pNETs).
A bicentric retrospective study was performed that included patients with histologically confirmed nf pNETs who were consecutively treated by EUS-RFA between December 2015 and March 2021 at two tertiary referral centers.
In 27 patients (mean age 65.0 years, 52% male), EUS-RFA was successfully performed. All patients had sporadic G1 lesions (mean size 14.0 ± 4.6 mm, 7% uncinated process, 22% head, 11% body, 19% body/tail junction, and 41% tail). Overall, 9/27 lesions (33%) were cystic. The mean hospital stay was 3.2 days. Complete treatment response was confirmed in 25/27 patients (93%) on cross-sectional imaging (mean follow-up 15.7 ± 12.2 months, range 2-41 months). Two patients had two EUS-RFA sessions until complete necrosis was observed. Periprocedural acute pancreatitis occurred in 4/27 (14.8%), three of them were treated by endoscopic cystogastrostomy (11.1%). One patient underwent secondary surgery. The histopathology of the resected specimen revealed 3 mm of residual tumor tissue.
EUS-RFA seems to be a promising treatment strategy for the management of small nf pNETs with excellent efficacy. Further evidence focusing on long-term survival, safety profile and recurrence is needed.
Keywords
Endoscopic ultrasound, endoscopic ultrasound-guided radiofrequency ablation, nonfunctional pancreatic neuroendocrine tumor, pancreatic tumor, endoscopic ultrasound, non-functional pancreatic neuroendocrine tumor
Pubmed
Web of science
Create date
03/01/2022 16:37
Last modification date
09/02/2022 7:33
Usage data